Company Name or Ticker Symbol
Search for other Categories

Neurotrope, Inc.  (NTRP)
Other Ticker:  

Cumulative Neurotrope's Quick Ratio for Trailing Twelve Months Period

NTRP's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth

NTRP Quick Ratio for Trailing Twelve Months Period

(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
(Dec 31 2017)
IV. Quarter
(Sep 30 2017)
III. Quarter
Y / Y Current Liabilities Growth 2.62 % -50.04 % -39.69 % -20.21 % 35.66 %
Y / Y Cash & cash equivalent Growth -47.76 % -44.94 % -38.99 % 147.29 % 108.2 %
Quick Ratio for Trailing Twelve Months Period 9.43 11.12 10.74 10.87 9.08
Total Ranking # 216 # 188 # 192 # 187 # 219
Seq. Current Liabilities Growth 56.85 % -7.07 % -24.66 % -6.56 % -23.64 %
Seq. Cash & cash equivalent Growth -17.57 % -18.48 % -10.02 % -13.6 % -13.12 %

Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to jump in Current Liabilities in the III. Quarter to $2 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 9.43 below Neurotrope, Inc. average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 51 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Neurotrope. While Quick Ratio for Trailing Twelve Months Period total ranking has deteriorated compare to previous quarter from 188 to 216.

What is Quick Ratio?
Learn more about NTRP
Quick Ratio NTRP in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 52
Sector # 87
S&P 500 # 211

Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
23.47 10.53 3.45
(June 30. 2014)   (Sep. 30, 2015)

Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2018, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Glycomimetics Inc  24.36 
Concert Pharmaceuticals, Inc.  23.85 
Medicinova Inc  22.42 
Crinetics Pharmaceuticals, Inc.  21.35 
Intra-cellular Therapies, Inc.  21.20 
Alpine Immune Sciences, Inc.  20.14 
Viking Therapeutics, Inc.  20.12 
Allakos Inc.  19.69 
Minerva Neurosciences, Inc.  19.13 
Xenon Pharmaceuticals Inc.  18.97 
Menlo Therapeutics Inc.  18.94 
Catalyst Pharmaceuticals, Inc.  18.30 
Flex Pharma, Inc.  17.56 
Abeona Therapeutics Inc.  17.50 
Magenta Therapeutics, Inc.  17.05 
Apellis Pharmaceuticals, Inc.  16.67 
Rocket Pharmaceuticals, Inc.  16.62 
Evolus, Inc.  16.27 
Spring Pharmaceutical Group, Inc.  16.25 
Nucana Plc  16.10 
Xeris Pharmaceuticals Inc  15.97 
Sage Therapeutics, Inc.  15.48 
Global Blood Therapeutics, Inc.  15.19 
Sierra Oncology, Inc.  15.10 
Kindred Biosciences, Inc.  14.88 
Enanta Pharmaceuticals Inc  14.60 
Albireo Pharma, Inc.  14.22 
Synlogic, Inc.  13.69 
Ophthotech Corp.  13.57 
Otonomy, Inc.  13.27 


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

VSAT's Profile

Stock Price

VSAT's Financials

Business Description


Charts & Quotes

VSAT's News


VSAT's Competitors

Customers & Markets

Economic Indicators

VSAT's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries





At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071